Close

Patient outcomes

RLD-patient-outcomes-resmed

 

NIV has been shown to improve daytime arterial blood gases and the symptoms associated with respiratory failure in patients with a chest wall disorder.1

  • Improved gas exchange with increased PO2 and decreased PCO2
  • Improved hemodynamics with decreased pulmonary artery pressure and increased right ventricular function
  • Reduced work of breathing
  • Normalised sleep patterns with fewer apneic episodes.
  • Fewer hospital admissions
  • Improved quality of life
  • Relief from dyspnoea

Reference

  1. Nickol AH, Hart N, Hopkinson NS, Moxham J, Simonds A, Polkey MI. (2005) Mechanisms of improvement of respiratory failure in patients with restrictive thoracic disease treated with non-invasive ventilation. Thorax Sep; 60(9):754-60

More RLD

What is restrictive lung disease?
Restrictive lung disease refers to conditions in which breathing is restricted, and can lead to long-term respiratory failure.
Why is it important to treat restrictive lung disease?
Treating the breathing and sleeping issues caused by restrictive lung disease disorders can make a huge difference in your quality of life.
Treatment options for restrictive lung disease (RLD)
ResMed has developed therapy devices and ventilators that can help you feel better during the day and sleep better at night, so you can get the most out of life.
By continuing to browse this site, you give consent for cookies to be used. We use cookies to give you the best possible experience on our website. Change settings or learn more. or Learn more

Manage your preferences regarding cookies

Please choose whether our website may use required and/or statistic/marketing cookies, as explained below:

Analytical Cookies

These cookies allow ResMed to analyze the website usage to measure and improve performance.

Advertising Cookies

These cookies are used to help better advertise depending on your interests.
By closing the popup, your preferences are kept throughout the session, until you change them.